The Dilemma and Resolution: The Patentability of Traditional Chinese Medicine

IF 1 Q4 BUSINESS

International Journal of Asian Business and Information Management Pub Date : 2012-07-01 DOI:10.4018/JABIM.2012070101

Xu Xuan, Zhang Xiao-wei

引用次数: 2

Abstract

Traditional Chinese Medicine (hereafter referred to as TCM) is made by Chinese herbal formulae and includes a ratio of pharmaceutical elements, which contain known health-enhancing functions. The trial process of the invention of TCM requires a lot of creative work and involves some risks. Winning patent protection for TCMs presents technical barriers on the patent examination. To address the problem of patent protection for TCM requires an understanding of history, medicine, pharmaceutical science, and modern drug development. The patentability of TCM may ultimately depend upon the determination of the scope and right contents of TCMs and the creation of a special patent examination system for this purpose.

查看原文本刊更多论文

困境与解决:中药的可专利性

中药(以下简称中药)是由中草药配方制成的，含有一定比例的药物成分，具有已知的保健功能。中药发明的试验过程需要大量的创造性工作，并且存在一定的风险。中药获得专利保护在专利审查中存在技术壁垒。要解决中药专利保护问题，需要对历史、医学、制药科学和现代药物开发有一定的了解。中药的可专利性最终可能取决于确定中药的范围和权利内容，并为此建立专门的专利审查制度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Asian Business and Information Management BUSINESS-

CiteScore

2.80

自引率

0.00%

发文量

期刊介绍： The mission of the International Journal of Asian Business and Information Management (IJABIM) is to establish an effective channel of communication between academic and research institutions, policy makers, government agencies, and individuals concerned with the complexities of Asian business, information technologies, sustained development, and globalization. IJABIM promotes and coordinates developments in the field of Asian and Chinese studies, as well as presents strategic roles of IT and management towards sustainable development with emphasis on practical aspects in Asia. It is especifically focused on Central Asia/Himalayan region/Southeast Asia/Far East.